We proudly support #InternationalWomenandGirlsinSTEMDay @unesco.org org has curated an immersive virtual exhibition taking visitors on a journey through history highlighting the achievements of women who have made groundbreaking contributions to in #STEM Learn more👇 www.unesco.org/en/virtual-s...

[ALA Client News] @vygongroup.bsky.social acquires Stiletto® and its SlipStream™ technology from Avia Vascular ala.associates/corporate/vy... #medicaldevices #vascularaccess

[ALA Client News] Kahimmune Therapeutics signs exclusive licensing agreement with @gustaveroussy.fr and SATT Paris-Saclay ala.associates/corporate/ka... #biotech #oncology

[Client News] Kayentis and @actigraph.bsky.social join forces to deliver integrated eCOA solution measuring and improving wearable technology adherence in clinical trials 👉Want to learn more? ala.associates/partnership/... #wearable #clinicaltrials

[Client News] En Carta Diagnostics receives @fda.gov Breakthrough Device Designation for EC Pocket Lyme test ala.associates/regulatory/e... #regulatory #diagnostics #LymeDisease

[Client News] Robocath launches First-In-Human (FIH) clinical study of second-generation robot with unique capabilities in coronary artery disease ala.associates/clinical/rob... #medtech #trial

[ALA Client News] ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate ala.associates/funding/ervi... #funding #biotech

[ALA Client News] Cathpax, with its new Nova-X system, demonstrates its ability to offer interventional physicians an unmatched level of radiation protection to prevent all radiation-induced diseases and musculoskeletal disorders ala.associates/clinical/cat... #medtech #cardiology

[ALA Client News] @vygongroup.bsky.social appoints new general manager to lead German subsidiary 🇩🇪 ala.associates/appointment/... #medicaldevices #hospital

[ALA Client News] Exciva raises €51 million ($59m) in Series B funding round co-led by Gimv and EQT ala.associates/funding/exci... #funding #Alzheimers

[ALA Client News] Bio-Sourcing and Zerion Pharma join forces to develop first HER2 oral monoclonal antibody against breast cancer ala.associates/partnership/... #EUgrant #breastcancer

[ALA Client News] @vygongroup.bsky.social appoints new general manager to lead UK subsidiary ala.associates/appointment/... #medicaldevices #hospital

Wishing you all a great year in 2026! 2025 has been a busy year for our clients with 67 news announcements, countless interviews and dozens of social media posts. As a result, more than 2,300 clippings! We thank our clients and partners for their trust. Kudos to the team for their achievements!

[ALA Client News] Novadip recruits first pediatric patients in pivotal phase 3 trial of tissue regenerative treatment NVD003 in congenital pseudoarthrosis of the tibia ala.associates/clinical/nov... #biotech #orphandisease

[ALA Client News] PLL Therapeutics opens subsidiary in New Zealand to accelerate ALS (Amyotrophic Lateral Sclerosis) treatment and early diagnostics breakthroughs ala.associates/corporate/pl... #biotech #ALS #subsidiary

[ALA Client News] Provepharm expands presence in medical dyes and enters fluorescence era ala.associates/corporate/pr... #pharma #surgicaldyes #fluorescence

[ALA Client News] SeaBeLife enters into joint development agreement with Unither Pharmaceuticals to formulate and produce ophthalmic drug candidate ala.associates/partnership/... #biotech #ophthalmology

[ALA Client News] BiPER Therapeutics secures €1M investment to advance first-in-class cancer therapy into clinical trials ala.associates/funding/bipe... #funding #cancer #clinicaltrials

[ALA Client News] Axoltis Pharma raises €18 million to accelerate development of Amyotrophic Lateral Sclerosis (ALS) drug candidate ala.associates/funding/axol... #ALS #funding #phase2trial

[ALA Client News] Archeon Medical: first responder study shows novel ventilation device triples survival rates without brain damage in #cardiacarrest care - US clinical trials to follow ala.associates/clinical/arc...

[ALA Client News] Adaptam Therapeutics raises €3 million to pioneer cancer immunotherapies against immunosuppressive myeloid cells 👉 ala.associates/funding/adap... #oncology #biotech

[ALA Client News] Naobios and Tokyo Metropolitan Institute of Medical Science partner to develop new live-attenuated vaccine against mpox Partnership aims to commercialize new mpox vaccine - with higher level of safety - by 2027 ala.associates/partnership/... #vaccine #mpox

[ALA Client News] Meteor Biotech launches in Europe with first deployment of spatial biology platform, CosmoSort, at VIB in Belgium 👉 ala.associates/product-laun... #SpatialBiology #Cancer #DrugDevelopment

[ALA Client News] Exeliom Biosciences secures €2.85M extension to Series A funding, bringing total round to nearly €12M ala.associates/funding/exel... #fundraising #immunomodulation #inflammatorydisease #oncology

[ALA Client News] SOM Biotech secures clear registrational path for SOM3355 in Huntington’s disease after @fda.gov End of Phase 2 Meeting ala.associates/regulatory/s... #huntingtonsdisease #neurology

[ALA client news] Avec le soutien de ses actionnaires historiques Téthys Invest, CVC et La Caisse (ex-CDPQ), Sebia annonce l’entrée en négociations exclusives en vue d’accueillir Warburg Pincus à son capital #diagnostic #oncologie ala.associates/corporate/se...

[ALA client news] Ciliatech opens US subsidiary and plans clinical trials in #glaucoma Initiative follows recent CE mark of Ciliatech’s flagship eye implant, a novel treatment for patients with mild to moderate glaucoma #glaucoma #USsubsidiary #clinicalresearch ala.associates/corporate/ci...

🔬 From flexible implants to circuits seeded with living cells, a new kind of electronics is starting to produce long-lasting implants with the potential to help everything from paralysis to hearing and vision loss - @newscientist.com www.newscientist.com/article/2492... #technology #medtech

At ALA, we’re proud to partner with Ciloa, a biotech pioneer engineering small extracellular vesicles (sEVs) for therapeutic and preventive use 🧬 We helped raise awareness of its €6.5M funding for advancement of its therapeutic option for metabolic diseases, such as #diabetes and #obesity💡

[ALA Client News] SeaBeLife secures €2 million ☑️ This funding will help fast-track the launch of clinical trials in dry AMD and severe acute hepatitis programs, with first clinical trial set to start in 2026 ala.associates/funding/seab... #ophthalmology #funding #biotech

[ALA Client News] RDS raises €14 million to industrialize MultiSense®, a connected patch for remote patient monitoring ala.associates/funding/rds-... #medtech #funding #wearables

[ALA Client News] Sonomind secures €3 million to advance its novel neuromodulation ultrasound device and opens a new therapeutic pathway in psychiatry and neurology ala.associates/funding/sono... @cnrs.fr @espciparispsl.bsky.social #neurology #funding #neuromodulation #depression

🖨️ #3DPrinting: Electronic devices that dissolve in water could make it easier to create and recycle technology prototypes – and they could even inspire more sustainable commercial devices - @jeremyhsu.bsky.social for @newscientist.com www.newscientist.com/article/2493... #sustainability

[ALA Client News] Genoskin Raises $8.7M Series A to Advance Ethical, Human Based Models That Deliver Reliable Insights for Safer, More Predictive Drug Development ala.associates/funding/geno... #drugdevelopment #immunotoxicology #funding

[ALA Client News] SOM Biotech receives positive EMA COMP opinion on European Orphan Drug Designation for SOM3355 for treatment of Huntington’s Disease 👉 ala.associates/regulatory/s... #huntingtonsdisease #neurology

Celebrating our clients' media successes🌟 Here are some of our recent highlights: 1️⃣ PLL Therapeutics in Drug Discovery World. PLL' CEO Jean-Pascal Zambaux presented the company's strategic approach for early detection and treatment of Amyotrophic Lateral Sclerosis (ALS) at Bioshares Biotech Summit

[ALA Client News] Naobios, Nuvonis and European Vaccine Initiative collaborate on manufacturing influenza challenge agent ala.associates/partnership/... #biotech #vaccines

[ALA Client News] BioWin Days 2025 : Belgian health innovators set to meet on September 23 and 24 ala.associates/events/belgi... #biotech #healthtech

[ALA Client News] Ciliatech obtains CE mark for eye implant Intercil® Uveal Spacer, novel treatment for patients with glaucoma ala.associates/regulatory/c... #Ophthalmology #Glaucoma #CEmark #ESCRS #MedTech

[ALA Client News] Meteor Biotech installs spatial biology platform, CosmoSort, at Magnify, CNSI incubator on UCLA campus ala.associates/partnership/... #SpatialCellSorting #DrugDevelopment #Oncology #Immunology #Neurology

[ALA Client News] Roca Therapeutics secures first-ever @ema.europa.eu recognition of Radiation Maculopathy as distinct indication - and Orphan Drug Designation ala.associates/regulatory/r... #Oncology #ClinicalTrials #Opthalmology #Radiotherapy

Researchers have developed antibiotics that can potentially kill drug-resistant gonorrhoea and MRSA with the help of artificial intelligence - @the-independent.com www.independent.co.uk/news/science... #antibiotics #antimicrobialresistance #AI

Scientists say this could be the start of a "new generation" of tech, capable of hacking the gut microbiome www.sciencefocus.com/news/gut-mic... #microbiome #guthealth #healthtech

Scientists have found the first robust evidence that genes affect chances of #ME/CFS, a mysterious and debilitating illness that has been neglected and dismissed for decades by many in the medical community - @iansample.bsky.social for @theguardian.com www.theguardian.com/society/2025...

[ALA Client News] PLL Therapeutics presents strategic approach for early detection and treatment of Amyotrophic Lateral Sclerosis (ALS) at Bioshares Biotech Summit 🧬 ala.associates/events/pll-t... #ALS #diagnostics #neurodegenerative

🦠 A UK government-funded study shows that without concerted action, increased rates of antimicrobial resistance (AMR) could lead to global annual GDP losses of $1.7tn over the next quarter of a century - @theguardian.com www.theguardian.com/society/2025... #AntimicrobialResistance #Antibiotics

💻 AI companies have now mostly abandoned the once-standard practice of including medical disclaimers and warnings in response to health questions, new research has found - @jamesmodonnell.bsky.social for @technologyreview.com www.technologyreview.com/2025/07/21/1... #AI #Healthcare

[ALA Client News] Corteria Pharmaceuticals initiates Phase 2 trial in heart failure and Phase 1 trial in obesity with its first-in-class CRF2 agonists Learn more here 👇 ala.associates/clinical/cor... #biotech #obesity #cardiovascular

Researchers have found the first new type of magnet in nearly a century. Now, these strange "altermagnets" could help us build an entirely new type of computer - @jacklinkwan.bsky.social for @newscientist.com www.newscientist.com/article/2487... #magnets #computing

AI-trained robot carries out procedures on dead pig organs to remove gall bladders without any human help - @robert-booth.bsky.social for @theguardian.com www.theguardian.com/science/2025... #AI #Surgery #Robotics